TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT05435274 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05392686 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT05382637 — Predictive Biomarker (PRD): GHR mRNA
Genes: GHR
Study NCT05382637 — Predictive Biomarker (PRD): Hormone receptor
Study NCT05330273 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT06123494 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05469659 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT04707625 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT04707625 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT05664087 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT05114421 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT05469347 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study NCT06286345 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05204628 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT06011772 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT06011772 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT06011772 — Predictive Biomarker (PRD): NRAS mRNA
Genes: NRAS; HRAS1
Study NCT06623903 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06294457 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06255392 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04681118 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT05180292 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00024115 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study NCT06538454 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05653518 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05653518 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05653518 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT05858619 — Predictive Biomarker (PRD): Interleukin 4 receptor alpha
Genes: IL4R; IL4RA; 582J2.1
Study NCT05758259 — Predictive Biomarker (PRD): VDR mRNA
Genes: VDR; NR1I1
Study NCT05758259 — Predictive Biomarker (PRD): CYP24A1 mRNA
Genes: CYP24A1; CYP24
Study NCT05758259 — Safety Biomarker (SAF): IL-6 and IL-10
Study NCT06623877 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT06398080 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT04612504 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study NCT05318391 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT05513599 — Monitoring Biomarker (MOI): Matrix metalloproteinase 8
Genes: MMP8; CLG1
Study NCT06206759 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT05559229 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study NCT04423627 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06593756 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04923906 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05848687 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05897255 — Predictive Biomarker (PRD): SEMG1 mRNA
Genes: SEMG1; SEMG
Study NCT06341478 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT05995106 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04856800 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05599334 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04764422 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT04961788 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT06383533 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05654623 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05654623 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT04800536 — Pharmacodynamic Biomarker (PDY): Blood coagulation
Study NCT06250348 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT05174403 — Predictive Biomarker (PRD): SPAG5 mRNA
Genes: SPAG5
Study NCT06539923 — Predictive Biomarker (PRD): SI mRNA
Genes: SI
Study NCT06539923 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT06539923 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study NCT05429008 — Predictive Biomarker (PRD): CD47 mRNA
Genes: CD47; MER6
Study NCT05477732 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05477732 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05477732 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05477732 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT05477732 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT05477732 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT05477732 — Predictive Biomarker (PRD): IL6
Genes: IL-6; BSF2; HGF; HSF
Study NCT05477732 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study NCT06718270 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CARTPT mRNA
Genes: CARTPT; CART
Study NCT00000859 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT05494580 — Predictive Biomarker (PRD): PARP1 mRNA
Genes: PARP1; ADPRT; PPOL
Study NCT05494580 — Predictive Biomarker (PRD): FLT4 mRNA
Genes: FLT4; VEGFR3
Study NCT05494580 — Predictive Biomarker (PRD): FGFR1 mRNA
Genes: FGFR1; BFGFR; CEK; FGFBR; FLG; FLT2; HBGFR
Study NCT05494580 — Predictive Biomarker (PRD): CSF1R mRNA
Genes: CSF1R; FMS
Study NCT05494580 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT05494580 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor receptor
Study NCT06433986 — Predictive Biomarker (PRD): MCAT mRNA
Genes: MCAT; MT
Study NCT05865678 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT06521684 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT06484790 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT01511822 — Surrogate Endpoint (SUR): Serum testosterone
Study NCT05550311 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT06110130 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT06110130 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06110130 — Predictive Biomarker (PRD): APOL1 mRNA
Genes: APOL1; APOL
Study NCT04804254 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT05609942 — Predictive Biomarker (PRD): KIT mRNA
Genes: KIT; SCFR
Study NCT05496608 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT06516978 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT05493813 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06195800 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT04840693 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06020456 — Predictive Biomarker (PRD): AVPR2 mRNA
Genes: AVPR2; ADHR; DIR; DIR3; V2R
Study NCT06020456 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study NCT06198673 — Predictive Biomarker (PRD): CCS mRNA
Genes: CCS
Study NCT04591808 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04591808 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT05640284 — Predictive Biomarker (PRD): TNFRSF11B mRNA
Genes: TNFRSF11B; OCIF; OPG
Study NCT05640284 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05938192 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study NCT06164119 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06164119 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06164119 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT06004401 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT05747261 — Pharmacodynamic Biomarker (PDY): Survival motor neuron protein
Genes: SMN1; SMN; SMNT;; SMN2; SMNC
Study NCT06409676 — Predictive Biomarker (PRD): ESD mRNA
Genes: ESD
Study NCT05584852 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study NCT05584852 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT05105204 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06649227 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT06649227 — Predictive Biomarker (PRD): RUNX1 mRNA
Genes: RUNX1; AML1; CBFA2
Study NCT06649227 — Predictive Biomarker (PRD): RUNX1T1 mRNA
Genes: RUNX1T1; AML1T1; CBFA2T1; CDR; ETO; MTG8; ZMYND2
Study NCT06566508 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06731127 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04926922 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT06526923 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT05287620 — Pharmacodynamic Biomarker (PDY): Leucine-rich repeat kinase 2
Genes: LRRK2; PARK8
Study NCT06589089 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CARTPT mRNA
Genes: CARTPT; CART
Study NCT05287906 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study NCT06550336 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study NCT05670587 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT05914974 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04595747 — Predictive Biomarker (PRD): SDS mRNA
Genes: SDS; SDH
Study NCT04595747 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor receptor
Study NCT05954442 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT05954442 — Predictive Biomarker (PRD): PAM mRNA
Genes: PAM
Study NCT06073717 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT06282978 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study NCT06282978 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT05378750 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06212648 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06568913 — Predictive Biomarker (PRD): TPO mRNA
Genes: TPO
Study NCT04981093 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT05411432 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00000625 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT06476171 — Safety Biomarker (SAF): Neutrophil to lymphocyte
Study NCT06476171 — Safety Biomarker (SAF): Platelet to lymphocyte
Study NCT05357742 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05275907 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04814004 — Predictive Biomarker (PRD): IL15 mRNA
Genes: IL15
Study NCT05569928 — Predictive Biomarker (PRD): ANGPTL3 mRNA
Genes: ANGPTL3; ANGPT5; UNQ153/PRO179
Study NCT04893356 — Predictive Biomarker (PRD): O-6-methylguanine-DNA-alkyltransferase
Genes: MGMT
Study NCT04687020 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT06585943 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT06080841 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT04889729 — Predictive Biomarker (PRD): PAFAH1B1 mRNA
Genes: PAFAH1B1; LIS1; MDCR; MDS; PAFAHA
Study NCT06083870 — Predictive Biomarker (PRD): TNFRSF10B mRNA
Genes: TNFRSF10B; DR5; KILLER; TRAILR2; TRICK2; ZTNFR9; UNQ160/PRO186
Study NCT06176599 — Safety Biomarker (SAF): Urinary microalbumin
Study NCT00766285 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05781594 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT05748093 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05748093 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT06081946 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05195008 — Safety Biomarker (SAF): Beta-N-acetylhexosaminidase
Genes: OGA; HEXC; KIAA0679; MEA5; MGEA5
Study NCT06247709 — Predictive Biomarker (PRD): KLHL14 mRNA
Genes: KLHL14; KIAA1384
Study NCT04731558 — Predictive Biomarker (PRD): ERAS mRNA
Genes: ERAS; HRAS2; HRASP
Study NCT06521333 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT05075538 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT01206959 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00002000 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT05438303 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT05438303 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT05438303 — Predictive Biomarker (PRD): CYP2C9 mRNA
Genes: CYP2C9; CYP2C10
Study NCT03705338 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06069375 — Predictive Biomarker (PRD): ACADM mRNA
Genes: ACADM
Study NCT06333509 — Predictive Biomarker (PRD): GPRC5D mRNA
Genes: GPRC5D
Study NCT06204198 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CTNNB1 mRNA
Genes: CTNNB1; CTNNB; OK/SW-cl.35; PRO2286
Study NCT05198596 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT06623786 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT06623786 — Safety Biomarker (SAF): Cytotoxic T-lymphocyte protein 4
Genes: CTLA4; CD152
Study NCT05051774 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05051774 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT05051774 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT06623279 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT06086340 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT06086340 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06086340 — Predictive Biomarker (PRD): Hormone receptor
Study NCT06086340 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT06730906 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06730477 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06730477 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04842812 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT04842812 — Safety Biomarker (SAF): Cytotoxic T-lymphocyte protein 4
Genes: CTLA4; CD152
Study NCT06096558 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06096558 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Intercellular adhesion molecule 1
Genes: ICAM1
Study NCT06096558 — Predictive Biomarker (PRD): Intact parathyroid hormone
Study NCT06096558 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT06096558 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT06096558 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05997641 — Predictive Biomarker (PRD): ALPK1 mRNA
Genes: ALPK1; KIAA1527; LAK
Study NCT05409261 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT04925609 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT05616260 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05095207 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06185153 — Predictive Biomarker (PRD): VIM mRNA
Genes: VIM
Study NCT05107466 — Predictive Biomarker (PRD): EP300 mRNA
Genes: EP300; P300
Study NCT06221475 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06221475 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06221475 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05393466 — Predictive Biomarker (PRD): BPI mRNA
Genes: BPI
Study NCT05606432 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05928962 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT05446545 — Monitoring Biomarker (MOI): Ovarian carcinoma antigen CA125
Genes: MUC16; CA125
Study NCT05446545 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT05093088 — Safety Biomarker (SAF): Nicotinamide phosphoribosyltransferase
Genes: NAMPT; PBEF; PBEF1
Study NCT05093088 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study NCT03559868 — Predictive Biomarker (PRD): PKM mRNA
Genes: PKM; OIP3; PK2; PK3; PKM2
Study NCT05733767 — Surrogate Endpoint (SUR): Exhaled carbon monoxide
Study NCT06290050 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT04805398 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT06440681 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Sclerostin
Genes: SOST; UNQ2976/PRO7455/PRO7476
Study NCT06440681 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Growth/differentiation factor 15
Genes: GDF15; MIC1; PDF; PLAB; PTGFB
Study NCT05839405 — Predictive Biomarker (PRD): DCX mRNA
Genes: DCX; DBCN; LISX
Study NCT06329037 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study NCT06358625 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06358625 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT06358625 — Predictive Biomarker (PRD): Hormone receptor
Study NCT05497336 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT05225116 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT05236972 — Predictive Biomarker (PRD): Microsatellite instability
Study NCT04943991 — Predictive Biomarker (PRD): GLA
Genes: GALA
Study NCT00915616 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT05220059 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05652101 — Predictive Biomarker (PRD): GLRB mRNA
Genes: GLRB
Study NCT00000955 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT05477667 — Predictive Biomarker (PRD): MYC mRNA
Genes: MYC; BHLHE39
Study NCT05477667 — Safety Biomarker (SAF): let-7a
Study NCT05146063 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study NCT05146063 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05136014 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03931252 — Predictive Biomarker (PRD): TEF mRNA
Genes: TEF; KIAA1655
Study NCT06407310 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT06505408 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT06574880 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT06445556 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04875312 — Predictive Biomarker (PRD): SHBG mRNA
Genes: SHBG
Study NCT00026026 — Predictive Biomarker (PRD): MSX1 mRNA
Genes: MSX1; HOX7
Study NCT00026026 — Predictive Biomarker (PRD): PAX9 mRNA
Genes: PAX9
Study NCT06273215 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT06273215 — Predictive Biomarker (PRD); Safety Biomarker (SAF): ABCG2
Genes: EST157481; MXR; BCRP; ABCP; CD338
Study NCT06273215 — Predictive Biomarker (PRD): SLCO1A2 mRNA
Genes: SLCO1A2; OATP; OATP1; OATP1A2; SLC21A3
Study NCT05198154 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT05045495 — Predictive Biomarker (PRD): SCT mRNA
Genes: SCT
Study NCT05486806 — Predictive Biomarker (PRD): TSPO mRNA
Genes: TSPO; BZRP; MBR
Study NCT05847179 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT05547243 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT06515392 — Predictive Biomarker (PRD): ABCD2 mRNA
Genes: ABCD2; ALD1; ALDL1; ALDR; ALDRP
Study NCT05654532 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05654532 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT05654532 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00002063 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT05044637 — Safety Biomarker (SAF): Glucose-6-phosphate dehydrogenase
Genes: G6PD
Study NCT05044637 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT04713228 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06036537 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06036537 — Predictive Biomarker (PRD): MUC5B mRNA
Genes: MUC5B; MUC5
Study NCT06036537 — Predictive Biomarker (PRD): KL mRNA
Genes: KL
Study NCT06036537 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT06701058 — Monitoring Biomarker (MOI): Matrix metalloproteinase 8
Genes: MMP8; CLG1
Study NCT06701188 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05228951 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT05228951 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06148220 — Predictive Biomarker (PRD): CD70 mRNA
Genes: CD70; CD27L; CD27LG; TNFSF7
Study NCT05873244 — Predictive Biomarker (PRD): HDAC8 mRNA
Genes: HDAC8; HDACL1; CDA07
Study NCT04777175 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT04777175 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT06601764 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT06704009 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT05650385 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT03904498 — Predictive Biomarker (PRD): COMT mRNA
Genes: COMT